Awarded
MARCHE SPECIFIQUEN°2 MEDICAMENT GCS PHDF 2025 : CIPROFLOXACINE VOIE INJECTABLE DOSAGE FAIBLE
Track this recordFree account — get alerted when a contract here runs out.
- Winners
- BAYER HEALTHCARE SAS
- Contract value
- no value published
- Published
- 7 Jan 2026
- Awarded
- 16 Dec 2025
- Contract start
- 16 Dec 2025
- Contract end
- 17 Dec 2026estimated
- Region
- Nord